Kamada (KMDA) Free Cash Flow (2012 - 2026)
Kamada (KMDA) posted quarterly Free Cash Flow of $682000.0 for Q1 2026, down 28.59% year-on-year from $955000.0 in Q1 2025, and down 86.48% on a QoQ basis from $5.0 million in Q4 2025.
Kamada (KMDA) Free Cash Flow (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Free Cash Flow for 15 consecutive years, with $682000.0 the latest figure, recorded in Q1 2026.
- Quarterly Free Cash Flow fell 28.59% year-over-year to $682000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29.8 million (down 41.3% YoY) and the FY2025 annual result came in at $35.3 million, down 22.57% from the prior year.
- Free Cash Flow retreated to $682000.0 in Q1 2026 per KMDA's latest filing, from $5.0 million in the prior quarter.
- Over the last five years, Free Cash Flow for KMDA reached as high as $24.3 million in Q3 2024 and fell as low as -$1734.0 in Q1 2023.
- A 5-year average of $6.6 million and a median of $5.0 million in 2025 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2023 — Free Cash Flow plunged 100.03% — and 2024, when it jumped 213594.81%.
- Year by year, Free Cash Flow stood at $983742.0 in 2022, then soared by 455.43% to $5.5 million in 2023, then soared by 54.52% to $8.4 million in 2024, then tumbled by 40.27% to $5.0 million in 2025, then slumped by 86.48% to $682000.0 in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered $682000.0, $5.0 million, and $14.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | 682,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 682,000.00 |
| Mar 31, 2026 | 682,000.00 |
| Dec 31, 2025 | 5.04 Mn |
| Dec 31, 2025 | 5.04 Mn |
| Sep 30, 2025 | 14.01 Mn |
| Sep 30, 2025 | 14.01 Mn |
| Jun 30, 2025 | 10.04 Mn |
| Jun 30, 2025 | 10.04 Mn |
| Mar 31, 2025 | 955,000.00 |
| Mar 31, 2025 | 955,000.00 |
| Dec 31, 2024 | 8.44 Mn |
| Dec 31, 2024 | 8.44 Mn |
| Sep 30, 2024 | 24.34 Mn |
| Sep 30, 2024 | 24.34 Mn |
| Jun 30, 2024 | 16.97 Mn |
| Jun 30, 2024 | 16.97 Mn |
| Mar 31, 2024 | 3.70 Mn |
| Mar 31, 2024 | 3.70 Mn |
| Dec 31, 2023 | 5.46 Mn |
| Dec 31, 2023 | 5.46 Mn |